ENDP - Endo International plc
| Previous Close | 5.52 |
| Open | 5.57 |
| Bid | 5.64 x 2300 |
| Ask | 5.65 x 3800 |
| Day's Range | 5.53 - 5.73 |
| 52 Week Range | 5.27 - 14.15 |
| Volume | 1,251,022 |
| Avg. Volume | 5,151,975 |
| Market Cap | 1.257B |
| Beta | -0.18 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -9.12 |
| Earnings Date | May 8, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8.81 |
- CNW Group•yesterday
Paladin Labs Inc. Announces Launch of New Indication for XIAFLEX® (Collagenase Clostridium Histolyticum), Broadening Its Use to the Treatment of Appropriate Patients with Peyronie's Disease
Paladin Labs Inc. Announces Launch of New Indication for XIAFLEX® (Collagenase Clostridium Histolyticum), Broadening Its Use to the Treatment of Appropriate Patients with Peyronie's Disease
- CNW Group•5 days ago
Paladin Labs Announces the Launch of Unisom® Snore Relief, the Only Natural Health Product Throat Spray Available in Canada to Help Relieve Symptoms Associated with Snoring
Paladin Labs Announces the Launch of Unisom® Snore Relief, the Only Natural Health Product Throat Spray Available in Canada to Help Relieve Symptoms Associated with Snoring
- Simply Wall St.•6 days ago
Are Earnings Prospects Improving For Loss-Making Endo International plc’s (NASDAQ:ENDP)?
After looking at Endo International plc’s (NASDAQ:ENDP) latest earnings announcement (31 December 2017), I found it useful to revisit the company’s performance in the past couple of years and assessRead More...
- PR Newswire•7 days ago
Endo Receives Paragraph IV Notification on Vasostrict®
DUBLIN , April 17, 2018 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that its subsidiaries, Par Pharmaceutical, Inc. and Par Sterile Products, LLC, have received a Notice Letter ...
- Zacks•11 days ago
Are Options Traders Betting on a Big Move in Endo International (ENDP) Stock?
Investors in Endo International (ENDP) need to pay close attention to the stock based on moves in the options market lately.
- PR Newswire•11 days ago
Endo to Announce First-Quarter 2018 Financial Results
DUBLIN , April 13, 2018 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) will announce its first-quarter 2018 financial results on May 8, 2018 and members of its senior management team will host ...
- GlobeNewswire•15 days ago
New Research: Key Drivers of Growth for Seagate Technology, AveXis, Banco Latinoamericano de Comercio Exterior, S.A, SunOpta, Orix Corp Ads, and Endo International plc — Factors of Influence, Major Initiatives and Sustained Production
NEW YORK, April 09, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
- MarketWatch•20 days ago
Opioid lawsuits stymie an Endo turnaround, Mizuho says in downgrade
Endo International PLC shares dropped 7% in Wednesday morning trade after the company was downgraded to neutral by Mizuho Securities due to "lower revenues, delayed pipeline contribution, lack of ...
- Zacks•21 days ago
What Falling Estimates & Price Mean for Endo International (ENDP)
Endo International (ENDP) has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions as well.
- PR Newswire•22 days ago
Endo Agrees to Extend Temporary Stay of FDA Litigation
DUBLIN , April 2, 2018 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that it has agreed to extend a temporary stay of its litigation against the U.S. Food and Drug Administration ...
- Reuters•26 days ago
Arkansas sues opioid manufacturers for roles in epidemic
Arkansas' attorney general on Thursday joined the widening mass of litigation against opioid manufacturers, accusing three drugmakers of promoting addictive painkillers in ways that falsely denied or trivialized their risks. Arkansas Attorney General Leslie Rutledge filed a lawsuit in state court in Little Rock accusing Purdue Pharma LP, Johnson & Johnson and Endo International Plc of engaging in misleading marketing practices. The case made Arkansas at least the 17th U.S. state to sue manufacturers of prescription opiods amid a nationwide epidemic of addiction to the painkillers.
- Zacks•26 days ago
Why Is Endo International (ENDP) Down 15% Since its Last Earnings Report?
Endo International (ENDP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- InvestorPlace•28 days ago
3 Sell-Rated Drug Stocks Investors Should Avoid for Now
The overall investor sentiment toward pharma and biotech stocks has improved of late as investors are focusing more on fundamentals than on issues like drug pricing. The year 2017 saw a number of drugs like Rhopressa, Tymlos, Ozempic, Vyzulta, Siliq, Trulance, Hemlibra, among others getting approval. Lutathera, Ilumya, Symdeko, Biktarvy, Erleada have already been approved in 2018 and investors are expected to keep their focus on the same. While 2017 was pretty ho-hum on this front with just a few key deals, 2018 is expected to see a surge in M&A primarily due to lower U.S. tax rates. Taking a clue from Gilead Sciences GILD acquisition of Kite Pharma, Celgene CELG recently acquired Juno Therapeutics to gain traction in the promising CAR-T space. Sanofi SNY acquired Bioverativ Inc. which focuses on therapies for hemophilia and other rare blood disorders.
- Zacks•28 days ago
3 Sell-Rated Drug Stocks Investors Should Avoid for Now
Despite a fairly upbeat performance of the pharma and biotech sector, caution has to be exercised before choosing a stock for investment as a few drug companies are struggling to revive business.
- Simply Wall St.•29 days ago
At $5.86, Is Endo International plc (NASDAQ:ENDP) A Buy?
Endo International plc (NASDAQ:ENDP), a pharmaceuticals company based in Ireland, received a lot of attention from a substantial price movement on the NasdaqGS in the over the last few months,Read More...
Markit•29 days agoSee what the IHS Markit Score report has to say about Endo International PLC.
Endo International PLC NASDAQ/NGS:ENDP
Markit•last monthSee what the IHS Markit Score report has to say about Endo International PLC.
Endo International PLC NASDAQ/NGS:ENDP
Markit•last monthSee what the IHS Markit Score report has to say about Endo International PLC.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last one-month, outflows of investor capital in ETFs holding ENDP totaled $3.23 billion.
- Reuters•last month
Endo, others to pay $270.8 mln to resolve Lidoderm U.S. antitrust cases
Endo International Plc and two other companies have agreed to pay $270.8 million to resolve class action lawsuits alleging Endo paid a generic drug manufacturer to delay launching a cheaper version of its Lidoderm painkiller patch. The accords were disclosed in papers filed in federal court in San Francisco on Tuesday and resolve claims centered on a deal Endo reached in 2012 to settle a patent infringement case it filed against generic drugmaker Watson Pharmaceuticals. The case is among several in recent years targeting "pay-for-delay" settlements, in which brand-name drugmakers resolve patent lawsuits by paying generic manufacturers to keep their products off the market for a longer period.
- Barrons.com•last month
Intraday Update: Dow Gains 115 Points Despite Looming Rate Hike
•...ponder how high the VIX might go. Tomorrow’s meeting of the Federal Reserve—where the central bankers are expected to hike interest rates—could hold some scary surprises. There may be good reason for that: It might be hard for the Fed to actually shock the market, writes JPMorgan strategist Dubravko Lakos-Bujas.
- CNBC•last month
Drug stocks dive as Trump says he's considering suing drugmakers over opioid crisis
President Donald Trump said he's considering suing drugmakers for their role in fueling the opioid epidemic, sending pharma stocks tumbling.
- Zacks•last month
Options Traders Expect Huge Moves in Endo International (ENDP) Stock
Investors in Endo International (ENDP) need to pay close attention to the stock based on moves in the options market lately.
Markit•last monthSee what the IHS Markit Score report has to say about Endo International PLC.
Endo International PLC NASDAQ/NGS:ENDP
- Zacks•last month
BioDelivery (BDSI) Q4 Loss Wider-Than-Expected, Sales Up Y/Y
BioDelivery (BDSI) reports wider-than-expected loss in Q4. However, revenues surpass estimates and increase substantially year over year.
Markit•last monthSee what the IHS Markit Score report has to say about Endo International PLC.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last month, growth of ETFs holding ENDP is favorable, with net inflows of $15.68 billion.
